JUN 27, 2019 09:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

CANCER ON A CHIP: A microfluidic 2D and 3D cell culture system for studying cellular microenvironment

Speakers
  • Post Doctoral Associate, Florida International University
    Biography
      Dr. Vivek Kamat received his Ph.D. from the University of Pune (India) in 2018. During his doctoral training under the supervision of Dr. Kishore Paknikar and Dr. Dhananjay Bodas at Agharkar Research Institute (Pune, India), he mastered the size-controlled synthesis of a variety of nanoparticles and the process of soft lithography fabricating complex microstructures using natural and artificial polymers. His work involved the size-controlled synthesis of drug-loaded nanoparticles and assessing their biological effect on cancer cell lines. Further Dr. Kamat worked in the area of tumor microenvironment specifically understanding cellular response and growth in confined volumes. He has experience in modeling and simulating biological system Insilco using COMSOL to study fluid dynamics, particle transport, and heat transfer. Dr.Kamat has experience working in interdisciplinary areas involving Cell biology, Nanotechnology, Electronics, and Microfabrication.

      Dr. Kamat joined the laboratory of Professor Shekhar Bhansali at Florida International University Department of Electrical engineering (FIU, Miami, USA) where he is working on understanding circulating tumor cells using electrical and optical methods to investigate cell-cell interactions and tumor microenvironment. He is also involved in integrating Artificial Intelligence and Machine learning to understand and predict cancer progression. He has active collaboration with Professor Kalai Matee at the Herbert Wertheim College of Medicine (FIU) working on transcriptomics analysis of cells growing in continuous flow conditions in microfluidic devices and along with his research he is involved in active teaching at the undergraduate level at FIU College of Engineering.

    Abstract:
    DATE:  June 27, 2019
    TIME:   9:00am PDT, 12:00pm EDT
     
    At present cancer research focuses on three major areas viz. cancer diagnostics, drugs development, and next-generation therapies. About 90% of the in-vitro research rely on traditional two-dimensional (2D) monolayer cell culture systems. 2D cell culture systems fail to accurately recapitulate the structure, function, physiology of living tissues, due to which the various studies such as assessing the efficacy of new drugs, study gene expressions, metabolic pathways, and cell proliferation do not correlate to actual In-vivo scenario. In contrast, a 3D cell culture system promotes many biological relevant functions which are not observed in 2D. The primary reason for this is attributed to two reasons: 1)In the real scenario cancer cells experience limited diffusion of oxygen, nutrients and signaling molecules in a dynamic way, which the 2D fails to mimmick. 2)Cellular interaction, function, growth and signaling all occurs in a highly complex 3D architecture with the influence of extracellular matrix and other regulatory factors, which cannot be recapitulated in 2D systems.

    To achieve this dynamic coordination microfluidic cell culture systems can be employed which can provide a continuous flow of nutrients, exchange of gases and other regulatory factors in a well-controlled manner. Such a system is ideal to mimic the in vivo environment of cells. The idea to couple microfluidics with 3D cell culture system will allow study of cellular functions such as proliferation in dynamic systems, cell-cell interaction and cellular response to the external environment in a much realistic environment. Further microfluidic systems give an opportunity to study cellular interaction by fabricating microstructures and artificial scaffolds to study cellular movements and the underlying mechanobiology. Using the microfluidic approach better drugs and therapies can be developed which can be easily translated to invivo systems and hence can bridge the gap between invitro and invivo system
     
    Learning Objectives:
    • Understand the difference between conventional and Microfluidic cell culture
    • learn the process of fabricating microfluidic cell culture chips and the requirements to establish a successful cell culture
    • Carrying out biological assay in microfluidic cell culture systems to understand cellular function
     
     
    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
     

    Show Resources
    You May Also Like
    MAY 16, 2019 04:00 PM CEST
    C.E. CREDITS
    MAY 16, 2019 04:00 PM CEST
    DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
    JUN 05, 2019 05:00 PM CEST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    FEB 26, 2019 09:00 AM PST
    C.E. CREDITS
    FEB 26, 2019 09:00 AM PST
    DATE:  February 26, 2019TIME:   9:00am PST, 12:00pm EST In an era of increasingly high-throughput, large-scale biology, with companies, government and non-prof...
    MAR 26, 2019 02:00 PM PDT
    C.E. CREDITS
    MAR 26, 2019 02:00 PM PDT
    DATE:  March 26, 2019TIME:  2:00pm PDT, 5:00pm EDT  Prostate cancer is the second most common form of cancer in males, affecting one in eight men by the time t...
    NOV 21, 2019 09:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    NOV 21, 2019 09:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: November 21, 2019TIME: 9:00am PST, 12:00pm EST Multiple Myeloma is a disease of terminally differentiated plasma cells with the massive production of monoclonal immunoglobu...
    MAY 21, 2019 07:00 AM PDT
    C.E. CREDITS
    MAY 21, 2019 07:00 AM PDT
    DATE: May 21, 2019TIMEL 7:00am PT, 10:00am ET Human T cells are central effectors of immunity and cancer immunotherapy. CRISPR-based functional studies in T cells could prioriti...
    Loading Comments...
    Show Resources
    Event Countdown
    • 0 Days
    • 0 Hours
    • 0 Minutes
    • 0 Seconds